Cited by 90Virus-based gene therapy researchRNA Interference and Gene DeliveryBarrier Structure and Function Studies

Transduction of Nonhuman Primate Brain with Adeno-Associated Virus Serotype 1: Vector Trafficking and Immune Response

Open access
Hadaczek, Piotr, Forsayeth, John, Mirek, Hanna, Munson, Keith, Bringas, John, Pivirotto, Phil, L McBride, Jodi, Davidson, Beverly L. +1 more·2009·Human Gene Therapy

Abstract

We used convection-enhanced delivery (CED) to characterize gene delivery mediated by adeno-associated virus type 1 (AAV1) by tracking expression of hrGFP (humanized green fluorescent protein from Renilla reniformis) into the striatum, basal forebrain, and corona radiata of monkey brain. Four cynomolgus monkeys received single infusions into corona radiata, putamen, and caudate. The other group (n = 4) received infusions into basal forebrain. Thirty days after infusion animals were killed and their brains were processed for immunohistochemical evaluation. Volumetric analysis of GFP-positive brain areas was performed. AAV1-hrGFP infusions resulted in approximately 550, 700, and 73 mm(3) coverage after infusion into corona radiata, striatum, and basal forebrain, respectively. Aside from targeted regions, other brain structures also showed GFP signal (internal and external globus pallidus, subthalamic nucleus), supporting the idea that AAV1 is actively trafficked to regions distal from the infusion site. In addition to neuronal transduction, a significant nonneuronal cell population was transduced by AAV1 vector; for example, oligodendrocytes in corona radiata and astrocytes in the striatum. We observed a strong humoral and cell-mediated response against AAV1-hrGFP in transduced monkeys irrespective of the anatomic location of the infusion, as evidenced by induction of circulating anti-AAV1 and anti-hrGFP antibodies, as well as infiltration of CD4(+) lymphocytes and upregulation of MHC-II in regions infused with vector. We conclude that transduction of antigen-presenting cells within the CNS is a likely cause of this response and that caution is warranted when foreign transgenes are used as reporters in gene therapy studies with vectors with broader tropism than AAV2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.2008.151

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Convection-enhanced delivery increases the vector volume that can be delivered to the target site and enhances cell transduction in the targeted CNS substructure.

    “This has the advantage of increased vector volume that can be delivered to the target site, which enhances cell transduction in the targeted CNS substructure”

    From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [78]

    The Introduction (page unavailable) says convection-enhanced delivery distributes vector at higher concentrations over a larger area than diffusion alone. The Results, ‘Distribution of hrGFP within the brain’ (page unavailable), report transduction volumes larger than the infused volumes. Neither passage establishes that CED increases the amount of vector that can be delivered to a target site; the claim appears to conflate delivered volume with distribution or transduction volume. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 48 · Cited by 90

Authors
Hadaczek, P., Forsayeth, J., Mirek, H., Munson, K., Bringas, J., Pivirotto, P., L McBride, J., Davidson, B. L., & Bankiewicz, K. S.
Affiliations
  • University of California, San Francisco (US)
  • Allozyne (United States) (US)
  • Department of Internal Medicine, University of Iowa, Iowa City, IA 52242.
  • University of Iowa (US)
Corresponding author
Hadaczek, Piotr
Venue
Human Gene Therapy
Published
2009-03
Volume
20
Issue
3
Pages
225-237
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W1979105421
Cited by
90
References
48
Citations by year
2025: 5 · 2023: 5 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 1 · 2014: 9 · 2013: 9 · 2012: 8
FWCI
6.24
Type
journal article
Language
en
Open access
Locations
  • Human Gene Therapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Hereditary Disease Foundation
  • National Institute of Neurological Disorders and Stroke (U54NS045309)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
gene therapy vectors, convection-enhanced delivery, non-human primate brain, Macaca fascicularis, immune response, humoral antibodies, cell-mediated immunity, CD4+ T cells, MHC class II, striatum, corona radiata, basal forebrain, oligodendrocytes, astrocytes, reporter transgenes
MeSH terms
Dependovirus, Animals, Antibody Formation, Astrocytes, Genetic Vectors, Humans, Infusions, Parenteral, Macaca fascicularis, Nervous System Diseases, Neurons, Oligodendroglia, Recombinant Proteins, Transduction, Genetic, Genetic Therapy, Prosencephalon, Green Fluorescent Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review